Blocking interleukin-6 activity with chimeric anti-IL6 monoclonal anitbodies in multiple myeloma: effects on soluble IL6 receptor and soluble gp130.

H.C.T. van Zaanen, H.M. Lokhorst, L.A. Aarden, H.J.A.M. Rensink, S.O. Warnaar, R.H.J. van Oers

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)551-558
Number of pages8
JournalLeukemia and Lymphoma
Volume31
Publication statusPublished - 1998

Cite this